MOD P00009 issued to exercise Option Year Three (3).

The Defense Logistics Agency plans a national requirements contract for Hydrochlorothiazide tablets in three strengths and various bottle counts. The contract will be firm-fixed price with a one-year base period and four one-year option periods. It will establish a national supply source for several federal agencies to purchase the medication through prime vendor programs. The acquisition is unrestricted and fully competitive for this commercial item. The projected solicitation date is April 2022, but the agency reserves the right to issue it before or after that date.